Catecholamine Induced Polymorphic Ventricular Tachycardia

Shrushti Dalal *

GMERS Medical College and Hospital, Gotri, Vadodara, Gujarat - 390020, India.

Prateek Dalal

Clinical Cardiology, Peconic Bay Medical Centre, Northwell Health, New York-11901, United States of America.

*Author to whom correspondence should be addressed.


Abstract

Aim: To describe a rare case of catecholamine induced polymorphic ventricular tachycardia.

Presentation of Case: Intermittent attacks of Ventricular fibrillation and syncope.

Summary: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial cardiac arrhythmia that is associated with ryanodine receptor gene (RYR2) or calsequestrin 2 (CASQ2) gene mutation. It is a rare condition that occurs in patients with structurally normal heart and leads to exercise/emotion triggered syncope and cause fatal arrhythmias. We present the case of a 21- year old female patient who was diagnosed with this condition at the age of 10 years and continues to live a healthy life.

Conclusion: Patients with CPSVT require life-long beta-blockers and might need an implanted defibrator.

Keywords: Catecholamine, ventricular tachycardia, sudden cardiac death


How to Cite

Dalal, Shrushti, and Prateek Dalal. 2022. “Catecholamine Induced Polymorphic Ventricular Tachycardia”. International Journal of Medical and Pharmaceutical Case Reports 15 (4):53-55. https://doi.org/10.9734/ijmpcr/2022/v15i430169.

Downloads

Download data is not yet available.